Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
11,507,819
-
Share change
-
+117,713
-
Total reported value
-
$497,600,700
-
Price per share
-
$43.24
-
Number of holders
-
88
-
Value change
-
-$9,385,943
-
Number of buys
-
46
-
Number of sells
-
41
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2020
As of 31 Mar 2020,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,507,819 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, FRAZIER MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Consonance Capital Management LP, VANGUARD GROUP INC, CREDIT SUISSE AG/, and CITADEL ADVISORS LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.